aSeptiMab

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameaSeptiMab

Drug Alias Nameanti-iNOS mAbs (DSX Therapeutics)DSX-ADSX-DDSX-IDSX-C

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionNitric oxide synthase, inducible inhibitors

TargetsNitric oxide synthase, inducible

Therapy Area/IndicationsSepsis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDSX Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDSX Therapeutics LLC

Active IndicationsN/A

Inactive IndicationsSepsis

Other Information

ATC CodeN/A